ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Shrikanth A.G. Reddy

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109410421; NIH RePORTER profile ID 1864320. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 grant

Papers 1

Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Co-author DOI 10.1016/j.freeradbiomed.2011.06.008 ↗

Grants 1

Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator R21CA161432 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Sushovan Guha · 1 shared grant, 2013 · strength 0.15
- Grant Ki-Ras Signaling in Pancreatic Cancer: Role of a Novel Akt Regulator R21CA161432 ↗
S Shin Kang · 1 shared paper, 2011 · strength 0.03
- Paper Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 … DOI 10.1016/j.freeradbiomed.2011.06.008 ↗
Koyamangalath Krishnan · 1 shared paper, 2011 · strength 0.03
- Paper Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 … DOI 10.1016/j.freeradbiomed.2011.06.008 ↗
Victoria E. Palau · 1 shared paper, 2011 · strength 0.03
- Paper Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 … DOI 10.1016/j.freeradbiomed.2011.06.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.